Zobrazeno 1 - 2
of 2
pro vyhledávání: '"on behalf of the Canadian Working Group"'
Autor:
Alia Thawer, Wilson H. Miller, Nancy Gregorio, Joël Claveau, Sudha Rajagopal, Kerry J. Savage, Xinni Song, Teresa M. Petrella, on behalf of the Canadian Working Group
Publikováno v:
Current Oncology, Vol 28, Iss 5, Pp 3537-3553 (2021)
The combination of dabrafenib and trametinib is a well-established treatment for BRAF-mutated melanoma. However, the effectiveness of this approach may be hindered by the development of treatment-related pyrexia syndrome, which occurs in at least 50%
Externí odkaz:
https://doaj.org/article/3f56bcf0d16b43c2b7eb07580b5f2ec1
Autor:
Thawer A; Department of Pharmacy, Sunnybrook Odette Cancer Centre, Toronto, ON M4N 3M5, Canada., Miller WH Jr; Departments of Medicine and Oncology, McGill University, Montreal, QC H3T 1E2, Canada., Gregorio N; Princess Margaret Cancer Centre, Toronto, ON M5T 2M9, Canada., Claveau J; Department of Internal Medicine, Dermatology Division, CHU de Québec, Université Laval, Quebec City, QC G1Y 0A1, Canada., Rajagopal S; Credit Valley Hospital, Mississauga, ON L5M 2N1, Canada., Savage KJ; Department of Medical Oncology, BC Cancer, The University of British Columbia, Vancouver, BC V5Z 1M9, Canada., Song X; Department of Internal Medicine, The Ottawa Hospital Cancer Centre, University of Ottawa, Ottawa, ON K1H 8L6, Canada., Petrella TM; Department of Medical Oncology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON M4N 3M5, Canada., On Behalf Of The Canadian Working Group
Publikováno v:
Current oncology (Toronto, Ont.) [Curr Oncol] 2021 Sep 14; Vol. 28 (5), pp. 3537-3553. Date of Electronic Publication: 2021 Sep 14.